Journal
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
Volume 13, Issue 10, Pages -Publisher
SPRINGER
DOI: 10.1007/s11910-013-0387-7
Keywords
Human immunodeficiency virus; HIV-associated neurocognitive disorders; Compartmentalization; Antiretroviral; Latency
Categories
Funding
- Intramural NIH HHS [ZIA NS003130-02] Funding Source: Medline
Ask authors/readers for more resources
Neurocognitive disorders are a feared complication of HIV infection, especially in the post-antiretroviral era as patients are living longer. These disorders are challenging in terms of diagnosis and treatment. The clinical syndrome has evolved, driven in part by comorbidities such as aging, drug abuse, psychiatric illnesses, and a metabolic syndrome associated with the use of antiretroviral drugs. Additionally some individuals may develop a fulminant immune reconstitution syndrome. Hence, treatment of these patients needs to be individualized. The focus of research in the HIV field has recently switched towards elimination of the HIV reservoir as a means of combating long-term HIV complications. However, these approaches may be suitable for limited populations and might not be applicable once the HIV reservoir has been established in the brain. Further, all clinical trials using neuroprotective or anti-inflammatory drugs for treatment of HIV-associated neurocognitive disorders have been unsuccessful. Hence, neurological complications of HIV infection are the biggest challenge facing HIV researchers, and there is a critical need to develop new diagnostics and approaches for treatment of these disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available